{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:06:17Z","timestamp":1792631177296,"version":"4.5.0"},"reference-count":49,"publisher":"American Association for Cancer Research (AACR)","issue":"5","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Infectious mononucleosis (IM) has been associated with an increased risk of Hodgkin lymphoma (HL), implicating a role for Epstein-Barr virus (EBV) in HL development. Although essential to the understanding of the association, it has remained uncertain if the relationship is restricted to the EBV-positive subset of HL. We collected information on mononucleosis history and childhood socioenvironmental characteristics in a population-based study of 586 patients with classic HL and 3,187 controls in Denmark and Sweden. Tumor EBV status was established for 499 cases by immunohistochemistry and in situ hybridization techniques. Odds ratios (OR) for the relationship between HL risk and mononucleosis and other risk factors were estimated by logistic regression for HL in younger (18\u201344 years) and older (45\u201374 years) adults, overall and by tumor EBV status. All analyses were adjusted for country-specific measures of maternal education and mononucleosis history. IM was associated with an increased risk of EBV-positive [OR, 3.23; 95% confidence interval (95% CI) 1.89\u20135.55] but not EBV-negative HL (OR, 1.35; 95% CI, 0.86\u20132.14). Risk of EBV-positive HL varied with time since IM and was particularly pronounced in younger adults (OR, 3.96; 95% CI, 2.19\u20137.18). IM-associated lymphomas occurred with a median of 2.9 years (1.8\u20134.9 years) after infection. The EBV specificity of the IM association was corroborated by a case-case comparison of IM history between younger adult EBV-positive and EBV-negative HL patients (ORIM EBV+ HL versus EBV\u2212 HL, 2.68; 95% CI, 1.40\u20135.12). We found further evidence that IM is associated only with EBV-positive HL. This finding is compatible with the notion that EBV-positive and EBV-negative HL may have different etiologies. [Cancer Res 2007;67(5):2382\u20138]<\/jats:p>","DOI":"10.1158\/0008-5472.can-06-3566","type":"journal-article","created":{"date-parts":[[2007,3,2]],"date-time":"2007-03-02T08:03:59Z","timestamp":1172822639000},"page":"2382-2388","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":145,"title":["Infectious Mononucleosis, Childhood Social Environment, and Risk of Hodgkin Lymphoma"],"prefix":"10.1158","volume":"67","author":[{"given":"Henrik","family":"Hjalgrim","sequence":"first","affiliation":[{"name":"1Department of Epidemiology Research, Statens Serum Institut and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Ekstro\u0308m Smedby","sequence":"additional","affiliation":[{"name":"3Institute of Medical Epidemiology and Biostatistics and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Rostgaard","sequence":"additional","affiliation":[{"name":"1Department of Epidemiology Research, Statens Serum Institut and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Molin","sequence":"additional","affiliation":[{"name":"5Departments of Oncology, Radiology, and Clinical Immunology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Hamilton-Dutoit","sequence":"additional","affiliation":[{"name":"7Institute of Pathology, Aarhus University Hospital, Aarhus, Denmark; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen T.","family":"Chang","sequence":"additional","affiliation":[{"name":"3Institute of Medical Epidemiology and Biostatistics and"},{"name":"8Northern California Cancer Center, Fremont, and Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Ralfkiaer","sequence":"additional","affiliation":[{"name":"2Institute of Pathology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christer","family":"Sundstro\u0308m","sequence":"additional","affiliation":[{"name":"6Genetics and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Olov","family":"Adami","sequence":"additional","affiliation":[{"name":"3Institute of Medical Epidemiology and Biostatistics and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bengt","family":"Glimelius","sequence":"additional","affiliation":[{"name":"4Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden;"},{"name":"5Departments of Oncology, Radiology, and Clinical Immunology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mads","family":"Melbye","sequence":"additional","affiliation":[{"name":"1Department of Epidemiology Research, Statens Serum Institut and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2007,3,1]]},"reference":[{"key":"2022061623232703000_B1","doi-asserted-by":"crossref","unstructured":"MacMahon B. Epidemiological evidence of the nature of Hodgkin's disease. Cancer\u20081957; 10: 1045\u201354.","DOI":"10.1002\/1097-0142(195709\/10)10:5<1045::AID-CNCR2820100527>3.0.CO;2-0"},{"key":"2022061623232703000_B2","unstructured":"MacMahon B. Epidemiology of Hodgkin's disease. Cancer Res\u20081966; 26: 1189\u2013201."},{"key":"2022061623232703000_B3","unstructured":"Henderson BE, Dworsky R, Pike MC, et al. Risk factors for nodular sclerosis and other types of Hodgkin's disease. Cancer Res\u20081979; 39: 4507\u201311."},{"key":"2022061623232703000_B4","doi-asserted-by":"crossref","unstructured":"Gutensohn N, Cole P. Childhood social environment and Hodgkin's disease. N Engl J Med\u20081981; 304: 135\u201340.","DOI":"10.1056\/NEJM198101153040302"},{"key":"2022061623232703000_B5","doi-asserted-by":"crossref","unstructured":"Bernard SM, Cartwright RA, Darwin CM, et al. Hodgkin's disease: case control epidemiological study in Yorkshire. Br J Cancer\u20081987; 55: 85\u201390.","DOI":"10.1038\/bjc.1987.18"},{"key":"2022061623232703000_B6","doi-asserted-by":"crossref","unstructured":"Bonelli L, Vitale V, Bistolfi F, Landucci M, Bruzzi P. Hodgkin's disease in adults: association with social factors and age at tonsillectomy. A case-control study. Int J Cancer\u20081990; 45: 423\u20137.","DOI":"10.1002\/ijc.2910450307"},{"key":"2022061623232703000_B7","doi-asserted-by":"crossref","unstructured":"Alexander FE, Ricketts TJ, McKinney PA, Cartwright RA. Community lifestyle characteristics and incidence of Hodgkin's disease in young people. Int J Cancer\u20081991; 48: 10\u20134.","DOI":"10.1002\/ijc.2910480103"},{"key":"2022061623232703000_B8","doi-asserted-by":"crossref","unstructured":"Westergaard T, Melbye M, Pedersen JB, Frisch M, Olsen JH, Andersen PK. Birth order, sibship size and risk of Hodgkin's disease in children and young adults: a population-based study of 31 million person-years. Int J Cancer\u20081997; 72: 977\u201381.","DOI":"10.1002\/(SICI)1097-0215(19970917)72:6<977::AID-IJC10>3.0.CO;2-2"},{"key":"2022061623232703000_B9","doi-asserted-by":"crossref","unstructured":"Chang ET, Montgomery SM, Richiardi L, Ehlin A, Ekbom A, Lambe M. Number of siblings and risk of Hodgkin's lymphoma. Cancer Epidemiol Biomarkers Prev\u20082004; 13: 1236\u201343.","DOI":"10.1158\/1055-9965.1236.13.7"},{"key":"2022061623232703000_B10","unstructured":"Mueller NE. Hodgkin's disease. In: Schottenfeld D, Fraumeni J, Jr., editors. Cancer epidemiology and prevention. 2nd ed. Oxford: Oxford University Press; 1996. p. 893\u2013919."},{"key":"2022061623232703000_B11","doi-asserted-by":"crossref","unstructured":"Rosdahl N, Olesen Larsen S, Thamdrup AB. Infectious mononucleosis in Denmark\u2014Epidemiological observations based on positive Paul-Bunnell reactions from 1940 to 1969. Scand J Infect Dis\u20081973; 5: 163\u201370.","DOI":"10.3109\/inf.1973.5.issue-3.02"},{"key":"2022061623232703000_B12","unstructured":"Connelly RR, Christine BW. A cohort study of cancer following infectious mononucleosis. Cancer Res\u20081974; 34: 1172\u20138."},{"key":"2022061623232703000_B13","doi-asserted-by":"crossref","unstructured":"Carter CD, Brown TM, Jr., Herbert JT, Heath CW, Jr. Cancer incidence following infectious mononucleosis. Am J Epidemiol\u20081977; 105: 30\u20136.","DOI":"10.1093\/oxfordjournals.aje.a112352"},{"key":"2022061623232703000_B14","doi-asserted-by":"crossref","unstructured":"Munoz N, Davidson RJ, Witthoff B, Ericsson JE, de The G. Infectious mononucleosis and Hodgkin's disease. Int J Cancer\u20081978; 22: 10\u20133.","DOI":"10.1002\/ijc.2910220104"},{"key":"2022061623232703000_B15","doi-asserted-by":"crossref","unstructured":"Kva\u030ale G, H\u00f8jby EA, Pedersen E. Hodgkin's disease in patients with previous infectious mononucleosis. Int J Cancer\u20081979; 23: 593\u20137.","DOI":"10.1002\/ijc.2910230502"},{"key":"2022061623232703000_B16","doi-asserted-by":"crossref","unstructured":"Serraino D, Franceschi S, Talamini R, et al. Socio-economic indicators, infectious disease and Hodgkin's disease. Int J Cancer\u20081991; 47: 352\u20137.","DOI":"10.1002\/ijc.2910470307"},{"key":"2022061623232703000_B17","doi-asserted-by":"crossref","unstructured":"Levine R, Zhu K, Gu Y, et al. Self-reported infectious mononucleosis and 6 cancers: a population-based, case-control study. Scand J Infect Dis\u20081998; 30: 211\u20134.","DOI":"10.1080\/00365549850160819"},{"key":"2022061623232703000_B18","doi-asserted-by":"crossref","unstructured":"Hjalgrim H, Askling J, Sorensen P, et al. Risk of Hodgkin's disease and other cancers after infectious mononucleosis. J Natl Cancer Inst\u20082000; 92: 1522\u20138.","DOI":"10.1093\/jnci\/92.18.1522"},{"key":"2022061623232703000_B19","doi-asserted-by":"crossref","unstructured":"Mueller N, Evans A, Harris NL, et al. Hodgkin's disease and Epstein-Barr virus. Altered antibody pattern before diagnosis. N Engl J Med\u20081989; 320: 689\u201395.","DOI":"10.1056\/NEJM198903163201103"},{"key":"2022061623232703000_B20","doi-asserted-by":"crossref","unstructured":"Johansson B, Klein G, Henle W, Henle G. Epstein-Barr virus (EBV)-associated antibody patterns in malignant lymphoma and leukemia. I. Hodgkin's disease. Int J Cancer\u20081970; 6: 450\u201362.","DOI":"10.1002\/ijc.2910060316"},{"key":"2022061623232703000_B21","doi-asserted-by":"crossref","unstructured":"Herbst H, Pallesen G, Weiss LM, et al. Hodgkin's disease and Epstein-Barr virus. Ann Oncol\u20081992; 3 Suppl 4: 27\u201330.","DOI":"10.1093\/annonc\/3.suppl_4.S27"},{"key":"2022061623232703000_B22","doi-asserted-by":"crossref","unstructured":"Glaser SL, Lin RJ, Stewart SL, et al. Epstein-Barr virus\u2013associated Hodgkin's disease: epidemiologic characteristics in international data. Int J Cancer\u20081997; 70: 375\u201382.","DOI":"10.1002\/(SICI)1097-0215(19970207)70:4<375::AID-IJC1>3.0.CO;2-T"},{"key":"2022061623232703000_B23","doi-asserted-by":"crossref","unstructured":"Alexander FE, Jarrett RF, Lawrence D, et al. Risk factors for Hodgkin's disease by Epstein-Barr virus (EBV) status: prior infection by EBV and other agents. Br J Cancer\u20082000; 82: 1117\u201321.","DOI":"10.1054\/bjoc.1999.1049"},{"key":"2022061623232703000_B24","doi-asserted-by":"crossref","unstructured":"Alexander FE, Lawrence DJ, Freeland J, et al. An epidemiologic study of index and family infectious mononucleosis and adult Hodgkin's disease (HD): evidence for a specific association with EBV+ve HD in young adults. Int J Cancer\u20082003; 107: 298\u2013302.","DOI":"10.1002\/ijc.11156"},{"key":"2022061623232703000_B25","unstructured":"IARC monographs on the evaluation of carcinogenic risks to humans: Epstein-Barr virus and Kaposi's sarcoma herpesvirus\/herpesvirus 8. Lyon: IARC; 1997."},{"key":"2022061623232703000_B26","doi-asserted-by":"crossref","unstructured":"Glaser SL, Keegan TH, Clarke CA, et al. Exposure to childhood infections and risk of Epstein-Barr virus\u2013defined Hodgkin's lymphoma in women. Int J Cancer\u20082005; 115: 599\u2013605.","DOI":"10.1002\/ijc.20787"},{"key":"2022061623232703000_B27","doi-asserted-by":"crossref","unstructured":"Thorley-Lawson DA, Gross A. Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med\u20082004; 350: 1328\u201337.","DOI":"10.1056\/NEJMra032015"},{"key":"2022061623232703000_B28","doi-asserted-by":"crossref","unstructured":"Ambinder RF. \u03b3-herpesviruses and \u201chit-and-run\u201d oncogenesis. Am J Pathol\u20082000; 156: 1\u20133.","DOI":"10.1016\/S0002-9440(10)64697-4"},{"key":"2022061623232703000_B29","doi-asserted-by":"crossref","unstructured":"Jarrett RF. Viruses and Hodgkin's lymphoma. Ann Oncol\u20082002; 13 Suppl 1: 23\u20139.","DOI":"10.1093\/annonc\/13.S1.23"},{"key":"2022061623232703000_B30","doi-asserted-by":"crossref","unstructured":"Armstrong AA, Alexander FE, Cartwright RA, et al. Epstein-Barr virus and Hodgkin's disease: further evidence for the three disease hypothesis. Leukemia\u20081998; 12: 1272\u20136.","DOI":"10.1038\/sj.leu.2401097"},{"key":"2022061623232703000_B31","doi-asserted-by":"crossref","unstructured":"Smedby KE, Hjalgrim H, Melbye M, et al. Ultraviolet radiation exposure and risk of malignant lymphomas. J Natl Cancer Inst\u20082005; 97: 199\u2013209.","DOI":"10.1093\/jnci\/dji022"},{"key":"2022061623232703000_B32","doi-asserted-by":"crossref","unstructured":"Ekstrom-Smedby K. Epidemiology and etiology of non-Hodgkin lymphoma\u2014a review. Acta Oncol\u20082006; 45: 258\u201371.","DOI":"10.1080\/02841860500531682"},{"key":"2022061623232703000_B33","unstructured":"Stein H, Delsol G, Pileri S, et al. Classical Hodgkin lymphoma. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. Tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2001. p. 244\u201353."},{"key":"2022061623232703000_B34","unstructured":"Stein H, Delsol G, Pileri S, et al. Nodular lymphocyte predominant Hodgkin lymphoma. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. Tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2001. p. 240\u20133."},{"key":"2022061623232703000_B35","doi-asserted-by":"crossref","unstructured":"Zhou XG, Sandvej K, Li PJ, et al. Epstein-Barr virus (EBV) in Chinese pediatric Hodgkin disease: Hodgkin disease in young children is an EBV-related lymphoma. Cancer\u20082001; 92: 1621\u201331.","DOI":"10.1002\/1097-0142(20010915)92:6<1621::AID-CNCR1488>3.0.CO;2-P"},{"key":"2022061623232703000_B36","doi-asserted-by":"crossref","unstructured":"Hjalgrim H, Askling J, Rostgaard K, et al. Characteristics of Hodgkin's lymphoma after infectious mononucleosis. N Engl J Med\u20082003; 349: 1324\u201332.","DOI":"10.1056\/NEJMoa023141"},{"key":"2022061623232703000_B37","doi-asserted-by":"crossref","unstructured":"Chang ET, Zheng T, Weir EG, et al. Childhood social environment and Hodgkin's lymphoma: new findings from a population-based case-control study. Cancer Epidemiol Biomarkers Prev\u20082004; 13: 1361\u201370.","DOI":"10.1158\/1055-9965.1361.13.8"},{"key":"2022061623232703000_B38","doi-asserted-by":"crossref","unstructured":"Evans AS, Niederman JC. Epstein-Barr virus. In: Evans AS, editor. Viral infections of humans. Epidemiology and control. 3rd ed. New York: Plenum Medical Book Company; 1989. p. 265\u201392.","DOI":"10.1007\/978-1-4613-0705-1_10"},{"key":"2022061623232703000_B39","unstructured":"Alexander FE, Jarrett RF, Cartwright RA, et al. Epstein-Barr virus and HLA-DPB1-*0301 in young adult Hodgkin's disease: evidence for inherited susceptibility to Epstein-Barr virus in cases that are EBV(+ve). Cancer Epidemiol Biomarkers Prev\u20082001; 10: 705\u20139."},{"key":"2022061623232703000_B40","doi-asserted-by":"crossref","unstructured":"Chang ET, Zheng T, Lennette ET, et al. Heterogeneity of risk factors and antibody profiles in Epstein-Barr virus genome-positive and -negative Hodgkin lymphoma. J Infect Dis\u20082004; 189: 2271\u201381.","DOI":"10.1086\/420886"},{"key":"2022061623232703000_B41","unstructured":"Sleckman BG, Mauch PM, Ambinder RF, et al. Epstein-Barr virus in Hodgkin's disease: correlation of risk factors and disease characteristics with molecular evidence of viral infection. Cancer Epidemiol Biomarkers Prev\u20081998; 7: 1117\u201321."},{"key":"2022061623232703000_B42","doi-asserted-by":"crossref","unstructured":"Jarrett RF, Stark GL, White J, et al. Impact of tumor Epstein-Barr virus status on presenting features and outcome in age-defined subgroups of patients with classic Hodgkin lymphoma: a population-based study. Blood\u20082005; 106: 2444\u201351.","DOI":"10.1182\/blood-2004-09-3759"},{"key":"2022061623232703000_B43","doi-asserted-by":"crossref","unstructured":"Keegan TH, Glaser SL, Clarke CA, et al. Epstein-Barr virus as a marker of survival after Hodgkin's lymphoma: a population-based study. J Clin Oncol\u20082005; 23: 7604\u201313.","DOI":"10.1200\/JCO.2005.02.6310"},{"key":"2022061623232703000_B44","doi-asserted-by":"crossref","unstructured":"Ponsonby AL, van dM I, Dwyer T, et al. Exposure to infant siblings during early life and risk of multiple sclerosis. JAMA\u20082005; 293: 463\u20139.","DOI":"10.1001\/jama.293.4.463"},{"key":"2022061623232703000_B45","doi-asserted-by":"crossref","unstructured":"Hjalgrim H, Askling J, Pukkala E, Hansen S, Munksgaard L, Frisch M. Incidence of Hodgkin's disease in Nordic countries. Lancet\u20082001; 358: 297\u20138.","DOI":"10.1016\/S0140-6736(01)05498-8"},{"key":"2022061623232703000_B46","unstructured":"Hartge P, Devesa SS, Fraumeni JF, Jr.. Hodgkin's and non-Hodgkin's lymphomas. Cancer Surv\u20081994; 19\/20: 423\u201353."},{"key":"2022061623232703000_B47","doi-asserted-by":"crossref","unstructured":"Mancao C, Altmann M, Jungnickel B, Hammerschmidt W. Rescue of \u201ccrippled\u201d germinal center B cells from apoptosis by Epstein-Barr virus. Blood\u20082005; 106: 4339\u201344.","DOI":"10.1182\/blood-2005-06-2341"},{"key":"2022061623232703000_B48","doi-asserted-by":"crossref","unstructured":"Chaganti S, Bell AI, Pastor NB, et al. Epstein-Barr virus infection in vitro can rescue germinal center B cells with inactivated immunoglobulin genes. Blood\u20082005; 106: 4249\u201352.","DOI":"10.1182\/blood-2005-06-2327"},{"key":"2022061623232703000_B49","doi-asserted-by":"crossref","unstructured":"Diepstra A, Niens M, Vellenga E, et al. Association with HLA class I in Epstein-Barr-virus\u2013positive and with HLA class III in Epstein-Barr-virus\u2013negative Hodgkin's lymphoma. Lancet\u20082005; 365: 2216\u201324.","DOI":"10.1016\/S0140-6736(05)66780-3"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/5\/2382\/2867119\/2382.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/5\/2382\/2867119\/2382.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T20:47:10Z","timestamp":1683751630000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/67\/5\/2382\/534075\/Infectious-Mononucleosis-Childhood-Social"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3,1]]},"references-count":49,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2007,3,1]]},"published-print":{"date-parts":[[2007,3,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-06-3566","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3,1]]}}}